1-3 of 3
Peter M. Ellis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study

Lauren Averett Byers, Dmitry Bentsion, Steven Gans, Konstantin Penkov, ChoonHee Son, Anne Sibille, Taofeek K. Owonikoko, Harry J.M. Groen, Carl M. Gay, Junya Fujimoto, Patricia de Groot, Martin Dunbar, Kingston Kang, Lei He, Vasudha Sehgal, Jaimee Glasgow, Bruce Allen Bach, Peter M. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 3884–3895.
https://doi.org/10.1158/1078-0432.CCR-20-4259
Published: 15 July 2021
View article titled, Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Open the PDF for Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study in another window
Includes: Supplementary data
Journal Articles

Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients

Peter M. Ellis, Rolf Kaiser, Yihua Zhao, Peter Stopfer, Steve Gyorffy, Nasser Hanna
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2881–2889.
https://doi.org/10.1158/1078-0432.CCR-09-2944
Published: 13 May 2010
View article titled, Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients
Open the PDF for Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients in another window
Journal Articles

Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer

Stephen Chia, Susan Dent, Susan Ellard, Peter M. Ellis, Ted Vandenberg, Karen Gelmon, Jean Powers, Wendy Walsh, Lesley Seymour, Elizabeth A. Eisenhauer
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (2): 708–713.
https://doi.org/10.1158/1078-0432.CCR-08-1159
Published: 15 January 2009
View article titled, Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer
Open the PDF for Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer in another window